These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19283768)

  • 1. Fabrication via a nonaqueous nanoprecipitation method, characterization and in vitro biological behavior of N(6)-cyclopentyladenosine-loaded nanoparticles.
    Dalpiaz A; Vighi E; Pavan B; Leo E
    J Pharm Sci; 2009 Nov; 98(11):4272-84. PubMed ID: 19283768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of parameters for preparation of docetaxel-loaded PLGA nanoparticles by nanoprecipitation method.
    Shi W; Zhang ZJ; Yuan Y; Xing EM; Qin Y; Peng ZJ; Zhang ZP; Yang KY
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):754-758. PubMed ID: 24142732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation.
    Betancourt T; Brown B; Brannon-Peppas L
    Nanomedicine (Lond); 2007 Apr; 2(2):219-32. PubMed ID: 17716122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid.
    Dalpiaz A; Contado C; Mari L; Perrone D; Pavan B; Paganetto G; HanuskovĂ  M; Vighi E; Leo E
    Drug Deliv; 2014 May; 21(3):221-32. PubMed ID: 24134683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
    Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
    Derakhshandeh K; Erfan M; Dadashzadeh S
    Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
    Ofokansi K; Winter G; Fricker G; Coester C
    Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition.
    Ling G; Zhang P; Zhang W; Sun J; Meng X; Qin Y; Deng Y; He Z
    J Control Release; 2010 Dec; 148(2):241-8. PubMed ID: 20727928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle formulation may affect the stabilization of an antiischemic prodrug.
    Leo E; Contado C; Bortolotti F; Pavan B; Scatturin A; Tosi G; Manfredini S; Angusti A; Dalpiaz A
    Int J Pharm; 2006 Jan; 307(1):103-13. PubMed ID: 16289882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single and double emulsion manufacturing techniques of an amphiphilic drug in PLGA nanoparticles: formulations of mithramycin and bioactivity.
    Cohen-Sela E; Teitlboim S; Chorny M; Koroukhov N; Danenberg HD; Gao J; Golomb G
    J Pharm Sci; 2009 Apr; 98(4):1452-62. PubMed ID: 18704956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monodisperse PLA/PLGA nanoparticle fabrication through a surfactant-free route.
    Liang R; Zhu J
    J Control Release; 2011 Nov; 152 Suppl 1():e129-31. PubMed ID: 22195799
    [No Abstract]   [Full Text] [Related]  

  • 16. PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: factor influence study and in vitro efficacy evaluation.
    Van de Ven H; Vermeersch M; Matheeussen A; Vandervoort J; Weyenberg W; Apers S; Cos P; Maes L; Ludwig A
    Int J Pharm; 2011 Nov; 420(1):122-32. PubMed ID: 21864661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced properties of discrete pulmonary deoxyribonuclease I (DNaseI) loaded PLGA nanoparticles during encapsulation and activity determination.
    Osman R; Kan PL; Awad G; Mortada N; El-Shamy AE; Alpar O
    Int J Pharm; 2011 Apr; 408(1-2):257-65. PubMed ID: 21335080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight.
    Leo E; Scatturin A; Vighi E; Dalpiaz A
    J Nanosci Nanotechnol; 2006; 6(9-10):3070-9. PubMed ID: 17048520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.